Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children

The objective is evaluation of GoCheck Kids, a smartphone application ('App'), for use as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Amblyopia Alzheimer Disease Brain Diseases Central Nervous System Diseases Dementia Eye Diseases Hyperopia Mental Disorders Myopia Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Refractive Errors Sensation Disorders Signs and Symptoms Tauopathies Vision Disorders

Age range

1 year–8 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Alaska Children's Eye & Strabismus

Anchorage, Alaska, 99508, United States

About this study

Detection of amblyopia risk factors using photo screening app in children of ages from 12 months to 8 years

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 12 months to 8 years inclusive.
Informed consent given by parent or legal guardian.

Exclusion criteria

History of ocular surgery and any condition that would preclude the ability of the investigator to obtain a reliable image and measurement

Treatment and study plan

App Vision Screening

Device

Using GoCheck Kids App Vision Screening to detect Amblyopia Risk Factors

Primary outcomes

Sensitivity and specificity of amblyopia risk factors detected by Photorefraction

Time frame: 1 day

Identification of risk factors compared to gold standard cycloplegic refraction

Secondary outcomes

Number of patients with gaze error identified by photo screening

Time frame: 1 day

Detection of gaze error compared to cover test examination results

Sponsors and collaborators

Lead sponsor

Gobiquity Mobile Health

Industry

Registry information

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Feb 27, 2018
Registry last updated: Aug 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed